Skip to main navigation Skip to search Skip to main content

MistraPharma – Identification and Reduction of Environmental Risks Caused by the Use of Human Pharmaceuticals

  • Andersen, Henrik Rasmus (Project Manager)

    Project Details

    Description

    Recommendations to improve wastewater treatment technologies. For the 30 highest ranked APIs we
    will evaluate the present loading of APIs, and the discharge of these compounds from the different types
    of Swedish wastewater treatment plants. This evaluation will form the basis for defining, evaluating and
    development of promising methods for removal of a APIs through wastewater treatment. In this procedure
    we can work with bench, pilot and, when possible, full-scale investigations. The most promising treatment
    technologies will be analyzed in detail concerning their costs and benefits, including any positive or
    negative side-effects that may be associated with their use, such as the working environment in the
    wastewater treatment plant, elimination or generation of additional compounds, quality changes of
    residual products, changes in energy use, or in the hygienic quality of the treated wastewater.
    AcronymMistraPharma
    StatusFinished
    Effective start/end date01/01/200831/12/2011

    Funding

    • Unknown

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.